MXPA04003679A - Formas de dosificacion, dispositivo y procedimientos de tratamiento. - Google Patents

Formas de dosificacion, dispositivo y procedimientos de tratamiento.

Info

Publication number
MXPA04003679A
MXPA04003679A MXPA04003679A MXPA04003679A MXPA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A
Authority
MX
Mexico
Prior art keywords
formulation
active agent
rumen
amounts
predetermined
Prior art date
Application number
MXPA04003679A
Other languages
English (en)
Inventor
Raymond Winkle Joseph
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3832213&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MXPA04003679(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MXPA04003679A publication Critical patent/MXPA04003679A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068Rumen, e.g. rumen bolus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/14Ectoparasiticides, e.g. scabicides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Inorganic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a un elemento de dosificacion de liberacion controlada adaptado para insertarse en y retenerse en el rumen de un animal rumiante. Dicho elemento comprende: a) una o mas cantidades pequenas y predeterminadas de al menos una primera formulacion que comprende al menos un primer agente activo, estando dicha formulacion adaptada para disolverse en los fluidos del rumen a una velocidad tal que la disolucion de cada una de dichas una o mas cantidades de la primera formulacion proporciona un episodio corto o en pulsos de liberacion de dicho primer agente activo en el rumen; y b) una o mas cantidades predeterminadas de al menos una segunda formulacion adaptada para disolverse a una velocidad controlada en los fluidos del rumen; en el que dichas una o mas cantidades de la primera formulacion se proporcionan en una o mas localizaciones predeterminadas dentro del elemento respecto de dichas una o mas cantidades de la segunda formulacion para una o mas liberaciones retardadas de al menos dicho primer agente activo en dicho rumen a tiempos predeterminados antes, durante y despues, o cualquier combinacion del mismo, de un periodo de tiempo extenso predeterminado definido por dicha segunda formulacion. La invencion tambien se refiere al procedimiento para liberar al menos un primer agente activo al rumen de un animal rumiante de forma retardada a uno o mas tiempos predeterminados tras la administracion a dicho animal de una composicion que contiene dicho agente activo, comprendiendo dicho procedimiento la administracion a dicho animal de un elemento de dosificacion de liberacion controlada segun la invencion. El primer agente activo se aplicara para el tratamiento, profilaxis o ambos de un estado patologico o de infestacion en un animal rumiante, o para alterar el estado fisiologico de un animal rumiante.
MXPA04003679A 2001-10-19 2002-10-18 Formas de dosificacion, dispositivo y procedimientos de tratamiento. MXPA04003679A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPR8390A AUPR839001A0 (en) 2001-10-19 2001-10-19 Dosage form, device and methods of treatment
PCT/AU2002/001426 WO2003033031A1 (en) 2001-10-19 2002-10-18 Dosage form, device and methods of treatment

Publications (1)

Publication Number Publication Date
MXPA04003679A true MXPA04003679A (es) 2004-07-23

Family

ID=3832213

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04003679A MXPA04003679A (es) 2001-10-19 2002-10-18 Formas de dosificacion, dispositivo y procedimientos de tratamiento.

Country Status (22)

Country Link
US (1) US20050064032A1 (es)
EP (1) EP1448151A4 (es)
JP (1) JP2005510485A (es)
KR (1) KR20050037410A (es)
CN (1) CN1571663A (es)
AR (1) AR037116A1 (es)
AU (5) AUPR839001A0 (es)
BR (1) BR0212975A (es)
CA (1) CA2463674A1 (es)
CR (1) CR7312A (es)
EA (1) EA005778B1 (es)
EC (1) ECSP045063A (es)
HR (1) HRP20040231A2 (es)
HU (1) HUP0401808A3 (es)
IL (1) IL160754A0 (es)
MX (1) MXPA04003679A (es)
NO (1) NO20041941L (es)
NZ (1) NZ531672A (es)
PE (1) PE20030519A1 (es)
PL (1) PL368387A1 (es)
WO (1) WO2003033031A1 (es)
ZA (1) ZA200403743B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRN20030021A1 (it) 2003-07-21 2005-01-22 Ascor Chimici Srl Composizione di materia comprendente particelle contenenti cloruro di colina da somministrare in forma ruminalmente protetta e post-ruminalmente efficace.
ITMI20041820A1 (it) * 2004-09-24 2004-12-24 Ascor Chimici Srl Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico.
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
AU2005320547B2 (en) * 2004-12-27 2009-02-05 Eisai R & D Management Co., Ltd. Method for stabilizing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
NZ554260A (en) * 2007-09-30 2010-05-28 Agres Ltd Selenomethionine andor selenocysteine administration to non-human animals to increase selenium content in protein sources
WO2010126857A1 (en) * 2009-04-28 2010-11-04 Wyeth Llc Parasiticidal combinations of macrocyclic lactones and polyether antibiotics
AU2014203209B2 (en) * 2009-07-31 2015-11-26 Boehringer Ingelheim Animal Health USA Inc. Sustained release capsules
EP2459116B1 (en) * 2009-07-31 2019-10-09 Boehringer Ingelheim Animal Health USA Inc. Sustained release capsules
US8980896B2 (en) * 2009-12-17 2015-03-17 Merial, Inc. Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
FR2992219B1 (fr) * 2012-06-22 2014-07-11 Aditec Lab Composition pour le traitement de l'hypocalcemie chez les ruminants
MX2017000041A (es) 2014-07-03 2017-05-01 Mallinckrodt Llc Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos.
CA3013321A1 (en) 2016-02-08 2017-08-17 SpecGx LLC Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties
WO2018102799A1 (en) * 2016-12-02 2018-06-07 Clexio Biosciences Ltd. Gastric residence system
US11147273B2 (en) * 2017-06-26 2021-10-19 Boehringer Ingelheim Animal Health USA Inc. Dual active parasiticidal granule compositions, methods and uses thereof
CA189877S (en) 2017-08-25 2021-02-18 Argenta Mfg Limited Intraruminal device
EP3849525A4 (en) * 2018-09-10 2022-06-08 Argenta Innovation Limited DELAYED RELEASE FORMULATIONS IN DISPENSING DEVICES
BR112021004523A2 (pt) * 2018-09-10 2021-06-08 Argenta Innovation Limited formulações para liberação sustentada em dispositivos de administração
US11478426B2 (en) 2018-09-25 2022-10-25 SpecGx LLC Abuse deterrent immediate release capsule dosage forms
AU2020328595B2 (en) * 2019-08-14 2023-07-13 Elanco Tiergesundheit Ag New wing protector for winged capsule and method of using same
WO2021158946A1 (en) * 2020-02-07 2021-08-12 Elanco Animal Health Incorporated Winged capsule
WO2021242481A1 (en) * 2020-05-28 2021-12-02 Boehringer Ingelheim Animal Health USA Inc. Bi-modal release intra-ruminal capsule device and methods of use thereof
SI4037666T1 (sl) 2020-12-08 2024-09-30 Ruminant Biotech Corp Limited Izboljšave naprav in postopkov za dostavo snovi živalim
CN113398337A (zh) * 2021-06-23 2021-09-17 上海市肺科医院 包含抗结核药物缓释植入人工骨载体的脊柱内固定装置

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
GB2077586A (en) * 1980-06-12 1981-12-23 Standard Telephones Cables Ltd Sustained-release device
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
US4416659A (en) * 1981-11-09 1983-11-22 Eli Lilly And Company Sustained release capsule for ruminants
NZ203203A (en) * 1982-02-16 1985-09-13 Commw Scient Ind Res Org Controlled release device:gas diffusion limited
IE54171B1 (en) * 1982-06-22 1989-07-05 Univ Glasgow Device for introducing nutrients and/or therapeutic materials into ruminant animals
GB8328916D0 (en) * 1983-10-28 1983-11-30 Castex Prod Pharmaceutical pellet
US4777049A (en) * 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
GR851195B (es) * 1984-06-02 1985-11-25 Castex Prod
US4723958A (en) * 1986-05-23 1988-02-09 Merck & Co., Inc. Pulsatile drug delivery system
US4867980A (en) * 1986-10-10 1989-09-19 Coopers Animal Health Australia Limited Heavy density depot
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5938654A (en) * 1987-06-25 1999-08-17 Alza Corporation Osmotic device for delayed delivery of agent
US4957494A (en) * 1987-06-25 1990-09-18 Alza Corporation Multi-layer delivery system
US4915949A (en) * 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
GB8829089D0 (en) * 1988-12-13 1989-01-25 Coopers Animal Health Intra ruminal device
DE59000232D1 (de) * 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US5110598A (en) * 1989-06-30 1992-05-05 Smithkline Beecham Corp. Intermittent release dosage form
US5126142A (en) * 1989-07-18 1992-06-30 Alza Corporation Dispenser comprising ionophore
US5017381A (en) * 1990-05-02 1991-05-21 Alza Corporation Multi-unit pulsatile delivery system
MX9200339A (es) * 1991-01-28 1992-08-01 Hoechst Ag Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
US5417682A (en) * 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
AU650113B2 (en) * 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5221278A (en) * 1992-03-12 1993-06-22 Alza Corporation Osmotically driven delivery device with expandable orifice for pulsatile delivery effect
BR9506533A (pt) * 1994-01-20 1997-09-16 Pastoral Agric Res Inst Nz Ltd Dispositivo para administração de materiais benéficos a ruminantes
AUPM897594A0 (en) * 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
PL205109B1 (pl) * 1998-11-02 2010-03-31 Elan Pharma Int Ltd Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
US6569857B1 (en) * 1999-05-03 2003-05-27 Drugtech Corporation Dietary supplement
DE19956486A1 (de) * 1999-11-24 2001-06-21 Lohmann Therapie Syst Lts Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen
EP1251864A4 (en) * 1999-12-31 2006-02-22 Univ Rutgers PHARMACEUTICAL FORMULATION COMPRISING A POLYMERIC MIXTURE AND AN ACTIVE COMPOUND FOR TIME-RELEASED RELEASE
AU2001237424A1 (en) * 2000-02-28 2001-09-12 Akzo Nobel N.V. Bodies for the controlled release of active substances

Also Published As

Publication number Publication date
AR037116A1 (es) 2004-10-20
US20050064032A1 (en) 2005-03-24
EA200400557A1 (ru) 2005-02-24
HUP0401808A3 (en) 2005-11-28
AU2004210542C1 (en) 2009-01-08
NO20041941L (no) 2004-05-10
CR7312A (es) 2004-10-27
IL160754A0 (en) 2004-08-31
CN1571663A (zh) 2005-01-26
JP2005510485A (ja) 2005-04-21
AU2002332975B2 (en) 2005-02-03
AU2002332975C1 (en) 2009-01-29
PE20030519A1 (es) 2003-06-13
ECSP045063A (es) 2004-05-28
AU2004210542B2 (en) 2005-07-28
ZA200403743B (en) 2005-05-16
AU2009250987A1 (en) 2010-01-14
CA2463674A1 (en) 2003-04-24
AU2004210542B9 (en) 2005-09-01
PL368387A1 (en) 2005-03-21
EP1448151A4 (en) 2010-01-13
AU2005227413A1 (en) 2005-11-17
WO2003033031A1 (en) 2003-04-24
EP1448151A1 (en) 2004-08-25
HRP20040231A2 (en) 2004-08-31
AU2004210542A1 (en) 2004-09-30
KR20050037410A (ko) 2005-04-21
HUP0401808A2 (hu) 2005-01-28
EA005778B1 (ru) 2005-06-30
NZ531672A (en) 2006-08-31
AU2002332975B9 (en) 2005-03-17
BR0212975A (pt) 2004-10-13
AUPR839001A0 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
MXPA04003679A (es) Formas de dosificacion, dispositivo y procedimientos de tratamiento.
AR040722A1 (es) Formulaciones y formas de dosificacion para la administracion controlada de topiramato
IL174562A0 (en) Oros push-stick for controlled delivery of active agent
NO993520L (no) Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon
WO2004017941A3 (en) Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist
WO2003039436A3 (es) Composiciones farmaceuticas que contienen oxibutinina
CY1107752T1 (el) Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης
MXPA02012792A (es) Composicion y forma de de dosificacion para liberacion gastrica retardada de alendronato y/u otros bis-fosfonatos.
HRP20050077B1 (hr) Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona
ATE312595T1 (de) Formulierung mit mehrfach gepulster wirkstofffreisetzung
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
JP2005510485A5 (es)
SE0102276D0 (sv) Device and method for the administration of a medicament
SG146638A1 (en) Pharmaceutical delivery system
HRP20240025T1 (hr) Liječenje bolesnika s klasičnom fabrijevom bolešću migalastatom
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
EP1550443A4 (en) COMPOSITION AGAINST STRESS-BASED DISEASES
MY122477A (en) Sertraline oral concentrate
MXPA03005384A (es) Composiciones framaceuticas de un inhibidor de bomba de proton revestido no enterico con una combinacion de sal de bicarbonato y sal de carbonato.
JPH0649646B2 (ja) 中枢性鎮痛剤の耐薬性発現抑制剤
Bardin Implantable contraception
RU2010144554A (ru) Средство для предотвращения и/или лечения сосудистых заболеваний
DE60321672D1 (de) Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids
DK1129714T3 (da) Anvendelse af tiludronsyre og dens derivater hos fjerkræ til fremstilling af et lægemiddel, der er beregnet til at forebygge og behandle osteoporose

Legal Events

Date Code Title Description
FG Grant or registration